Legal Opinion
Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
District Court, D. New Jersey
Decided June 23, 1998No. Civ. 98-2006(WGB), 98-2143 (JAG)PublishedCited by 8 opinions
1Opinion of the Court
OPINION
BASSLER, District Judge.
Plaintiff Ben Venue Laboratories, Inc., a generic drug manufacturer, moves for a preliminary injunction requiring Defendant Novartis Pharmaceuticals Corp., a brand name drug manufacturer, to remove its patent from the Food and Drug Administration’s “Orange Book.” Plaintiff subsequently filed a motion for leave to file a supplemental complaint. Defendant has filed a motion to dismiss this action pursuant to Fed.R.Civ.P. 12(b)(1). Jurisdiction in this Court is pursuant to 28 U.S.C. §§ 1331 and 1332. For the reasons set forth below, the Court denies Defendant’s…
2Cases cited18 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Caterpillar Inc. v. LewisSupreme Court of the United States · 1996
- United Sav. Assn. of Tex. v. Timbers of Inwood Forest Associates, Ltd.Supreme Court of the United States · 1988
- Gustafson v. Alloyd Co.Supreme Court of the United States · 1995
- Mathews v. DiazSupreme Court of the United States · 1976
13 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Mylan Pharmaceuticals, Inc. v. ShalalaDistrict Court, District of Columbia · 2000
- A.K. Stamping Co. v. Instrument Specialties Co.District Court, D. New Jersey · 2000
- Mylan Pharmaceuticals, Inc. v. ThompsonDistrict Court, District of Columbia · 2001
- Andrx Pharmaceuticals, Inc. v. Biovail Corp.Court of Appeals for the Federal Circuit · 2002
- Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.District Court, D. New Jersey · 2001
3 more not listed; retrieve them via the Exa API.